Portfolio company
Causaly
United Kingdom · £52.1m raised
Raised
£52.1m
Latest stage
Series B
Rounds recorded
3
Backed by
4 investors
Sectors
About
Causaly provides an AI platform that interprets cause-and-effect relationships in biomedical literature for researchers and decision makers in pharmaceutical, biotech, and healthcare organisations.
SourceFunding history · 3
Similar companies
Biorelate
This company develops an artificial intelligence platform that curates biomedical data to support drug discovery for pharmaceutical and life sciences organisations.
CytoReason
CytoReason develops computational disease models and AI software for pharmaceutical and biotechnology companies to support data-driven drug discovery and development decisions.
Vaalia Health
This company develops a medication management platform using causal artificial intelligence to support cancer patients with treatment adherence for pharmaceutical manufacturers and healthcare providers.
Huma.AI
This company develops a generative artificial intelligence platform for life sciences and pharmaceutical organisations to automate data analysis and insight generation from unstructured datasets.
Capsule AI
This company develops autonomous agent systems that conduct scientific research and strategic analysis for pharmaceutical and biotechnology organisations.
Theorema
This company builds causal disease models for pharmaceutical and biotech firms to identify drug targets and find new indications for existing assets.
DistillerSR
This company develops AI-enabled literature review software to automate evidence-based research for pharmaceutical, medical device, and academic organisations.
Atropos Health
This company develops a data platform that provides real-world evidence and clinical insights to healthcare providers and life science organisations.
